# Role of Octreotide in Non Variceal Bleeding

> **NCT06062719** · PHASE2,PHASE3 · UNKNOWN · sponsor: **National Hepatology & Tropical Medicine Research Institute** · enrollment: 56 (estimated)

## Conditions studied

- Non-variceal Gastrointestinal Bleeding

## Interventions

- **DRUG:** PPI group
- **DRUG:** PPI plus octreotide

## Key facts

- **NCT ID:** NCT06062719
- **Lead sponsor:** National Hepatology & Tropical Medicine Research Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-23
- **Primary completion:** 2024-09
- **Final completion:** 2025-01
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2023-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06062719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06062719, "Role of Octreotide in Non Variceal Bleeding". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06062719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*